BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2573163)

  • 1. [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)].
    Freche JP; Decolin D; Siest JP; Batt AM; Panis-Rouzier R; Siest G
    Therapie; 1989; 44(5):327-30. PubMed ID: 2573163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
    Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.
    Heinemeyer G; Roots I; Lestau P; Klaiber HR; Dennhardt R
    Br J Clin Pharmacol; 1986 Jan; 21(1):9-18. PubMed ID: 2868749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
    Rost KL; Mansmann U; Roots I
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):14-8. PubMed ID: 9021436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo.
    Hildebrandt AG; Roots I; Speck M; Saalfrank K; Kewitz H
    Eur J Clin Pharmacol; 1975 Jun; 8(5):327-36. PubMed ID: 9297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism].
    Zhiri A; Wellman-Bednawska M; Siest G
    Pathol Biol (Paris); 1987 Sep; 35(7):1087-93. PubMed ID: 3313218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
    Galteau MM; Shamsa F
    Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenobarbital on unconjugated bilirubin clearance, gamma-glutamyltranspeptidase and urinary d-glucaric acid in patients with Gilbert's syndrome.
    Kawasaki H; Murawaki Y; Kimura N; Hirayama C
    Hepatogastroenterology; 1982 Dec; 29(6):252-5. PubMed ID: 6130037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary 6 beta-hydroxycortisol in humans: analysis, biological variations, and reference ranges.
    Lee C
    Clin Biochem; 1995 Feb; 28(1):49-54. PubMed ID: 7720227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
    Hermida J; Fernández MP; Tutor JC
    Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 12. A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans.
    Bienvenu T; Rey E; Pons G; d'Athis P; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):441-5. PubMed ID: 1800391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and dose-dependent enzyme induction by omeprazole in human beings.
    Rost KL; Brösicke H; Heinemeyer G; Roots I
    Hepatology; 1994 Nov; 20(5):1204-12. PubMed ID: 7927253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man.
    Latham AN; Turner P; Franklin C; Maclay W
    Can J Physiol Pharmacol; 1976 Oct; 54(5):778-82. PubMed ID: 991005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction.
    Saenger P
    Clin Pharmacol Ther; 1983 Dec; 34(6):818-21. PubMed ID: 6641098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antipyrine and rifampicin on the excretion of renal enzymes in human urine.
    Wensing G; Maruhn D; Ohnhaus EE
    Clin Nephrol; 1988 Feb; 29(2):69-74. PubMed ID: 2896083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods to study enzyme induction in man.
    Roots I; Saalfrank K; Hildebrandt AG
    Adv Exp Med Biol; 1975; 58(00):485-502. PubMed ID: 239546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed excretion of 6 beta-hydroxycortisol in lead-toxic children.
    Saenger P; Markowitz ME; Rosen JF
    J Clin Endocrinol Metab; 1984 Feb; 58(2):363-7. PubMed ID: 6420437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6 beta-Hydroxycortisol: a noninvasive indicator of enzyme induction.
    Saenger P; Forster E; Kream J
    J Clin Endocrinol Metab; 1981 Mar; 52(3):381-4. PubMed ID: 7462397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in urinary levels of free 6 beta-hydroxycortisol, cortisol, and estrogens in late pregnancy.
    Hunter DJ; Keane P; Walker WH; YoungLai EV
    Gynecol Obstet Invest; 1984; 18(2):83-7. PubMed ID: 6541177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.